Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(1R,2R)-2-(methylamino)-1,2-diphenylethan-1-ol, commonly known as pseudoephedrine, is a sympathomimetic drug that functions as a decongestant. It is characterized by its ability to constrict blood vessels in the nasal passages, which helps alleviate the swelling and congestion associated with allergies and the common cold.

1081548-91-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1081548-91-5 Structure
  • Basic information

    1. Product Name: (1R,2R)-2-(methylamino)-1,2-diphenylethan-1-ol
    2. Synonyms: (1R,2R)-2-(methylamino)-1,2-diphenylethan-1-ol
    3. CAS NO:1081548-91-5
    4. Molecular Formula:
    5. Molecular Weight: 227.306
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1081548-91-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (1R,2R)-2-(methylamino)-1,2-diphenylethan-1-ol(CAS DataBase Reference)
    10. NIST Chemistry Reference: (1R,2R)-2-(methylamino)-1,2-diphenylethan-1-ol(1081548-91-5)
    11. EPA Substance Registry System: (1R,2R)-2-(methylamino)-1,2-diphenylethan-1-ol(1081548-91-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1081548-91-5(Hazardous Substances Data)

1081548-91-5 Usage

Uses

Used in Pharmaceutical Industry:
Pseudoephedrine is utilized as an active ingredient in various over-the-counter and prescription medications for its decongestant properties. It is commonly found in the form of pills or nasal sprays to treat nasal congestion caused by allergies and the common cold.
Used in Regulatory Measures:
Due to its potential for misuse in the production of methamphetamine, pseudoephedrine is subject to strict regulations on its sale and distribution in many countries. This is to prevent its diversion for illicit purposes and ensure that it is used safely and as directed by healthcare professionals.

Check Digit Verification of cas no

The CAS Registry Mumber 1081548-91-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,1,5,4 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1081548-91:
(9*1)+(8*0)+(7*8)+(6*1)+(5*5)+(4*4)+(3*8)+(2*9)+(1*1)=155
155 % 10 = 5
So 1081548-91-5 is a valid CAS Registry Number.

1081548-91-5Relevant articles and documents

Synthesis of novel phase transfer catalysts derived from proline-mandelic acid/tartaric acid: their evaluation in enantioselective epoxidation and Darzen condensation

Mahajan, Deepak P,Godbole, Himanshu M,Singh, Girij P,Shenoy, Gautham G

, (2019)

Abstract : Herein, we have described the synthesis of novel chiral cyclic phase transfer catalysts (PTCs). These catalysts are synthesized from proline, mandelic acid and tartaric acid by using simple synthetic methods with competitive yields. These chira

Practical Gram-Scale Synthesis of Iboxamycin, a Potent Antibiotic Candidate

Mason, Jeremy D.,Myers, Andrew G.,Pote, Aditya R.,Terwilliger, Daniel W.

supporting information, p. 11019 - 11025 (2021/08/03)

A gram-scale synthesis of iboxamycin, an antibiotic candidate bearing a fused bicyclic amino acid residue, is presented. A pivotal transformation in the route involves an intramolecular hydrosilylation-oxidation sequence to set the ring-fusion stereocenters of the bicyclic scaffold. Other notable features of the synthesis include a high-yielding, highly diastereoselective alkylation of a pseudoephenamine amide, a convergent sp3-sp2 Negishi coupling, and a one-pot transacetalization-reduction reaction to form the target compound's oxepane ring. Implementation of this synthetic strategy has provided ample quantities of iboxamycin to allow for its in vivo profiling in murine models of infection.

LINCOSAMIDE ANTIBIOTICS AND USES THEREOF

-

Paragraph 00382, (2021/11/26)

Provided are compounds of Formula (I) for the treatment of infectious and inflammatory diseases. The compounds described herein are lincosamides modified at the amino acid (southern) region. The compounds may have further modification at the C-7 position of the aminooctose (northern) region, thus distinguishing them from lincomycin and clindamycin. Also provided are methods for preparing the compounds, pharmaceutical compositions comprising the compounds, and methods of treating infectious diseases using the disclosed compounds.

LINCONSAMIDE ANTIBIOTICS AND USES THEREOF

-

Paragraph 00359, (2019/02/25)

Provided are lincosamide compounds for the treatment of infectious diseases. The lincosamides described herein are modified at the amino acid (southern) region. The lincosamides may have further modification at the C-1 and C-7 positions of the aminooctose (northern) region, thus distinguishing them from lincomycin and clindamycin. Also provided are methods for preparing the lincosamide compounds, pharmaceutical compositions comprising the lincosamide compounds, and methods of treating infectious diseases using the disclosed lincosamide compounds.

Large-scale preparation of key building blocks for the manufacture of fully synthetic macrolide antibiotics

Hogan, Philip C.,Chen, Chi-Li,Mulvihill, Kristen M.,Lawrence, Jonathan F.,Moorhead, Eric,Rickmeier, Jens,Myers, Andrew G.

, p. 318 - 325 (2018/03/21)

Key building blocks for the production of fully synthetic macrolides have been scaled-up in first time pilot plant and kilo-lab campaigns. These building blocks have supported the discovery of new macrolide antibiotics as well as ongoing preclinical studies.

MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE

-

Paragraph 00315; 00316, (2015/07/16)

Described herein are monobactam antibiotics of Formula (I), (Ι'), (II), and (II'), along with methods and intermediates for preparing these compounds. Pharmaceutical compositions and methods of treating infectious diseases using the monobactams are also p

Stereocontrolled synthesis of syn-β-hydroxy-α-amino acids by direct aldolization of pseudoephenamine glycinamide

Seiple, Ian B.,Mercer, Jaron A. M.,Sussman, Robin J.,Zhang, Ziyang,Myers, Andrew G.

supporting information, p. 4642 - 4647 (2014/05/20)

β-Hydroxy-α-amino acids figure prominently as chiral building blocks in chemical synthesis and serve as precursors to numerous important medicines. Reported herein is a method for the synthesis of β-hydroxy- α-amino acid derivatives by aldolization of pseudoephenamine glycinamide, which can be prepared from pseudoephenamine in a one-flask protocol. Enolization of (R,R)- or (S,S)-pseudoephenamine glycinamide with lithium hexamethyldisilazide in the presence of LiCl followed by addition of an aldehyde or ketone substrate affords aldol addition products that are stereochemically homologous with L- or D-threonine, respectively. These products, which are typically solids, can be obtained in stereoisomerically pure form in yields of 55-98 %, and are readily transformed into β-hydroxy-α-amino acids by mild hydrolysis or into 2-amino-1,3-diols by reduction with sodium borohydride. This new chemistry greatly facilitates the construction of novel antibiotics of several different classes. On aldol: Enolization of (R,R)- or (S,S)-pseudoephenamine glycinamide with lithium hexamethyldisilazide (LiHMDS) in the presence of LiCl followed by addition of either an aldehyde or ketone substrate affords aldol addition products which are stereochemically homologous with L- or D-threonine, respectively. These products can be obtained in stereoisomerically pure form in yields of 55-98 %, and are readily transformed into β-hydroxy-α-amino acids by mild hydrolysis or into 2-amino-1,3-diols by reduction.

A simple, scalable synthetic route to (+)- and (-)-pseudoephenamine

Mellem, Kevin T.,Myers, Andrew G.

supporting information, p. 5594 - 5597 (2013/11/19)

A three-step synthesis of pseudoephenamine suitable for preparing multigram amounts of both enantiomers of the auxiliary from the inexpensive starting material benzil is described. The sequence involves synthesis of the crystalline monomethylimine derivat

Pseudoephenamine: A practical chiral auxiliary for asymmetric synthesis

Morales, Marvin R.,Mellem, Kevin T.,Myers, Andrew G.

, p. 4568 - 4571 (2012/06/30)

Unrestricted: Pseudoephenamine is introduced as a versatile chiral auxiliary and an alternative to pseudoephedrine in asymmetric synthesis. It is free from regulatory restrictions and leads to remarkable stereocontrol in alkylation reactions, especially in those that form quaternary carbon centers. Amides derived from pseudoephenamine exhibit a high propensity to be crystalline substances, and provide sharp, well-defined signals in NMR spectra. Copyright

Aminophosphine phosphinites derived from chiral 1,2-diphenyl-2-aminoethanols: Synthesis and application in rhodium-catalyzed asymmetric hydrogenation of dehydroamino acid derivatives

Lou, Rongliang,Mi, Aiqiao,Jiang, Yaozhong,Qin, Yong,Li, Zhi,Fu, Fangmin,Chan, Albert S.C

, p. 5857 - 5863 (2007/10/03)

A series of chiral aminophosphine phosphinites DPAMPPs was synthesized from optically active 1,2-diphenyl-2-aminoethanols. The erythro-DPAMPPs were found to serve as excellent ligands for rhodium-catalyzed asymmetric hydrogenation of dehydroamino acid derivatives. For an array of dehydroamino acid precursors, remarkably high enantioselectivity (up to 98.4% e.e.) and reactivity (the ratio of substrate/catalyst up to 10000) were observed. Some factors controlling the enantioselectivity were examined and discussed. (C) 2000 Elsevier Science Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1081548-91-5